[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ] [more data in EconPapers] [trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]
IF | AIF | CIF | IF5 | DOC | CDO | CIT | NCI | CCU | D2Y | C2Y | D5Y | C5Y | SC | %SC | CiY | II | AII | |
1999 | 0 | 0.39 | 0 | 0 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.26 | |||||
2002 | 0 | 0.54 | 0 | 0 | 1 | 4 | 0 | 0 | 0 | 3 | 0 | 0 | 0.31 | |||||
2003 | 0 | 0.53 | 0 | 0 | 1 | 5 | 0 | 0 | 1 | 4 | 0 | 0 | 0.3 | |||||
2010 | 0 | 0.52 | 0 | 0 | 2 | 7 | 1 | 1 | 0 | 0 | 0 | 0 | 0.3 | |||||
2011 | 0 | 0.62 | 0 | 0 | 3 | 10 | 1 | 1 | 2 | 2 | 0 | 0 | 0.37 | |||||
2012 | 0.2 | 0.68 | 0.08 | 0.2 | 2 | 12 | 0 | 1 | 2 | 5 | 1 | 5 | 1 | 1 | 100 | 0 | 0.36 | |
2014 | 0 | 0.67 | 0.13 | 0.14 | 3 | 15 | 2 | 2 | 4 | 2 | 7 | 1 | 0 | 1 | 0.33 | 0.34 | ||
2015 | 0 | 0.65 | 0.11 | 0 | 3 | 18 | 7 | 6 | 3 | 10 | 0 | 0 | 0.36 | |||||
2016 | 0.33 | 0.64 | 0.11 | 0.18 | 1 | 19 | 1 | 2 | 8 | 6 | 2 | 11 | 2 | 0 | 0 | 0.34 | ||
2017 | 0.25 | 0.62 | 0.1 | 0.11 | 2 | 21 | 1 | 2 | 10 | 4 | 1 | 9 | 1 | 0 | 0 | 0.35 | ||
2018 | 0.33 | 0.61 | 0.21 | 0.44 | 3 | 24 | 0 | 5 | 15 | 3 | 1 | 9 | 4 | 0 | 0 | 0.34 | ||
2019 | 0 | 0.62 | 0.04 | 0 | 1 | 25 | 0 | 1 | 16 | 5 | 12 | 0 | 0 | 0.36 | ||||
2020 | 0.25 | 0.7 | 0.13 | 0.3 | 6 | 31 | 0 | 4 | 20 | 4 | 1 | 10 | 3 | 0 | 0 | 0.74 |
IF: | Two years Impact Factor: C2Y / D2Y |
AIF: | Average Impact Factor for all series in RePEc in year y |
CIF: | Cumulative impact factor |
IF5: | Five years Impact Factor: C5Y / D5Y |
DOC: | Number of documents published in year y |
CDO: | Cumulative number of documents published until year y |
CIT: | Number of citations to papers published in year y |
NCI: | Number of citations in year y |
CCU: | Cumulative number of citations to papers published until year y |
D2Y: | Number of articles published in y-1 plus y-2 |
C2Y: | Cites in y to articles published in y-1 plus y-2 |
D5Y: | Number of articles published in y-1 until y-5 |
C5Y: | Cites in y to articles published in y-1 until y-5 |
SC: | selft citations in y to articles published in y-1 plus y-2 |
%SC: | Percentage of selft citations in y to articles published in y-1 plus y-2 |
CiY: | Cites in year y to documents published in year y |
II: | Immediacy Index: CiY / Documents. |
AII: | Average Immediacy Index for series in RePEc in year y |
# | Year | Title | Cited |
---|---|---|---|
1 | 2015 | Multi-indication Pricing: Pros, Cons and Applicability to the UK. (2015). Towse, Adrian ; Pistollato, M ; Dellamano, R ; Mestre-Ferrandiz, J. In: Seminar Briefings. RePEc:ohe:sembri:001653. Full description at Econpapers || Download paper | 6 |
2 | 2016 | Waiting Time Policies in the Health Sector. (2016). Siciliani, Luigi. In: Seminar Briefings. RePEc:ohe:sembri:001724. Full description at Econpapers || Download paper | 2 |
3 | 2010 | Science Policy Research: Having an Impact on Policy?. (2010). Martin, Ben. In: Seminar Briefings. RePEc:ohe:sembri:000197. Full description at Econpapers || Download paper | 2 |
4 | 2015 | A Framework for Payer Assessment of the Value of New Technologies: A US Approach. (2015). Pearson, S. In: Seminar Briefings. RePEc:ohe:sembri:001589. Full description at Econpapers || Download paper | 2 |
5 | 2011 | Willingness to Pay and Publicly Funded Health Care: Contradiction in Terms?. (2011). Donaldson, C. In: Seminar Briefings. RePEc:ohe:sembri:000173. Full description at Econpapers || Download paper | 2 |
6 | 2014 | Biosimilar Competition: Lessons from Europe and Prospects for the US. (2014). Grabowski, H. In: Seminar Briefings. RePEc:ohe:sembri:001556. Full description at Econpapers || Download paper | 2 |
7 | 2017 | Delivering an Outcomes-based NHS: Creating the Right Conditions. (2017). Hicks, N. In: Seminar Briefings. RePEc:ohe:sembri:001804. Full description at Econpapers || Download paper | 2 |
8 | 2003 | Mental Health Economics and Policy in a Global Context. (2003). Sussex, J. In: Seminar Briefings. RePEc:ohe:sembri:000482. Full description at Econpapers || Download paper | 1 |
9 | 2014 | Can the US Afford to Ignore Cost-effectiveness Evidence?. (2014). Chambers, J. In: Seminar Briefings. RePEc:ohe:sembri:000074. Full description at Econpapers || Download paper | 1 |
10 | 1999 | Public Involvement in Priority Setting. (1999). Ed, L. In: Seminar Briefings. RePEc:ohe:sembri:000451. Full description at Econpapers || Download paper | 1 |
11 | 2019 | Early Experience with Health Technology Assessment of Gene Therapies in the United States: Pricing and Paying for Cures. (2019). Pearson, S. In: Seminar Briefings. RePEc:ohe:sembri:002112. Full description at Econpapers || Download paper | 1 |
12 | 2012 | Value Based Pricing in Sweden: Lessons for Design?. (2012). Persson, U. In: Seminar Briefings. RePEc:ohe:sembri:000141. Full description at Econpapers || Download paper | 1 |
# | Year | Title | Cited |
---|
Year | Title |
---|